Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Life After STroke - the LAST Study. A Norwegian Multi Centre Randomized Controlled Trial
Brief Summary: The LAST study is a Norwegian multi site randomised controlled trial that intends to assess the effect of a long term follow up program after stroke. The program consists of a coordinating physiotherapist who will encourage and motivate included patients to perform at least 60 minutes of intensive motor training every week and 30 minutes of physical activity every day for 18 months after inclusion. The primary hypothesis is that patients receiving a long term follow up program after stroke will have better motor function at end of follow up than patients receiving standard care. A total of 390 home dwelling stroke patients living in the municipality of Trondheim, Asker and Bærum will be included at the out-patient clinic at St. Olavs Hospital or Bærum Hospital three months after their stroke. Included patients will be randomised to an intervention group receiving the long term follow up program or to a control group receiving standard care. Motor function, mental health and physical functioning in daily life will be assessed at inclusion and 18 months later. The LAST study is funded by the Norwegian Research Council, the Norwegian University of Science and Technology and the Central Norway Regional Health Authority and will conclude at the end of 2015.


Options:
A: Arm Label: Long term follow up program; Type: EXPERIMENTAL; Interventions: Behavioral: Long term follow up by a coordinating physiotherapist | Arm Label: Standard care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Standard care | Intervention Type: BEHAVIORAL; Name: Long term follow up by a coordinating physiotherapist; Assigned to Arm(s): Long term follow up program | Intervention Type: BEHAVIORAL; Name: Standard care; Assigned to Arm(s): Standard care
B: Arm Label: non-invasive brain stimulation; Type: EXPERIMENTAL; Interventions: Device: Transcranial Direct Current Stimulation | Intervention Type: DEVICE; Name: Transcranial Direct Current Stimulation; Assigned to Arm(s): non-invasive brain stimulation
C: Arm Label: real tDCS; Type: EXPERIMENTAL; Interventions: Device: tDCS | Arm Label: sham tDCS; Type: SHAM_COMPARATOR; Interventions: Device: tDCS | Arm Label: no stimulation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: tDCS; Assigned to Arm(s): real tDCS, sham tDCS
D: Arm Label: RBX + tDCS; Type: EXPERIMENTAL; Interventions: Drug: reboxetine, Device: tDCS verum | Arm Label: RBX + sham stimulation; Type: ACTIVE_COMPARATOR; Interventions: Drug: reboxetine, Device: tDCS sham | Arm Label: PLC + tDCS; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Device: tDCS verum | Arm Label: PLC + sham stimulation; Type: SHAM_COMPARATOR; Interventions: Drug: Placebo, Device: tDCS sham | Intervention Type: DRUG; Name: reboxetine; Assigned to Arm(s): RBX + sham stimulation, RBX + tDCS | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): PLC + sham stimulation, PLC + tDCS | Intervention Type: DEVICE; Name: tDCS verum; Assigned to Arm(s): PLC + tDCS, RBX + tDCS | Intervention Type: DEVICE; Name: tDCS sham; Assigned to Arm(s): PLC + sham stimulation, RBX + sham stimulation

Answer: A